Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jialei Hu, Lei Jiao, Yuemei Hu, Kai Chu, Jingxin Li, Fengcai Zhu, Taishun Li, Zhiyuan Wu, Dong Wei, Fanyue Meng & Bingxiang Wang. (2018) One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study. Human Vaccines & Immunotherapeutics 14:11, pages 2701-2705.
Read now
Read now
Shih-shiung Huang, I-Hsun Li, Po-da Hong & Ming-kung Yeh. (2014) Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague. International Journal of Nanomedicine 9, pages 813-822.
Read now
Read now
Qingwen Zhang, Qiong Wang, Guang Tian, Zhizhen Qi, Xuecan Zhang, Xiaohong Wu, Yefeng Qiu, Yujing Bi, Xiaoyan Yang, Youquan Xin, Jian He, Jiyuan Zhou, Lin Zeng, Ruifu Yang & Xiaoyi Wang. (2014) Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques. Human Vaccines & Immunotherapeutics 10:2, pages 368-377.
Read now
Read now
Xiaoyi Wang, Xuecan Zhang, Dongsheng Zhou & Ruifu Yang. (2013) Live-attenuated Yersinia pestis vaccines. Expert Review of Vaccines 12:6, pages 677-686.
Read now
Read now
Valentina A Feodorova & Vladimir L Motin. (2012) Plague vaccines: current developments and future perspectives. Emerging Microbes & Infections 1:1, pages 1-5.
Read now
Read now
Valentina A Feodorova & Michael J Corbel. (2009) Prospects for new plague vaccines. Expert Review of Vaccines 8:12, pages 1721-1738.
Read now
Read now
Stephen T Smiley. (2008) Current challenges in the development of vaccines for pneumonic plague. Expert Review of Vaccines 7:2, pages 209-221.
Read now
Read now
Articles from other publishers (105)
Sven Kalbitz, Nils Kellner, Martin Macholz, Jörg Ermisch, Jana Fechner & Christoph Lübbert. (2023) Erkrankungen durch hochpathogene Erreger – Teil 2. Krankenhaushygiene up2date 18:01, pages 37-55.
Crossref
Crossref
Saugata Majumder, Rachel M. Olson, Amit Singh, Xiuran Wang, Peng Li, Hatem Kittana, Paul E. Anderson, Deborah M. Anderson & Wei Sun. (2022)
Protection Induced by Oral Vaccination with a Recombinant
Yersinia pseudotuberculosis
Delivering
Yersinia pestis
LcrV and F1 Antigens in Mice and Rats against Pneumonic Plague
. Infection and Immunity 90:8.
Crossref
Crossref
Chen Lei & Suresh Kumar. (2022) Yersinia pestis antibiotic resistance: a systematic review. Osong Public Health and Research Perspectives 13:1, pages 24-36.
Crossref
Crossref
Wei Zhang, Xiaolin Song, Lina Zhai, Jianshu Guo, Xinying Zheng, Lili Zhang, Meng Lv, Lingfei Hu, Dongsheng Zhou, Xiaolu Xiong & Wenhui Yang. (2022) Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation. Frontiers in Immunology 13.
Crossref
Crossref
Raysa Rosario-Acevedo, Sergei S. Biryukov, Joel A. Bozue & Christopher K. Cote. (2021) Plague Prevention and Therapy: Perspectives on Current and Future Strategies. Biomedicines 9:10, pages 1421.
Crossref
Crossref
Jason A. Rosenzweig, Emily K. Hendrix & Ashok K. Chopra. (2021) Plague vaccines: new developments in an ongoing search. Applied Microbiology and Biotechnology 105:12, pages 4931-4941.
Crossref
Crossref
Christina D'Arco, Alison A. McCormick & Paul M. Arnaboldi. (2021) Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection. Vaccine 39:9, pages 1435-1444.
Crossref
Crossref
Punit Kumar, Sunita, Kashyap Kumar Dubey & Pratyoosh Shukla. 2021. Vaccine Delivery Technology. Vaccine Delivery Technology
249
266
.
E. A. Krasil'nikova, A. S. Trunyakova, A. S. Vagaiskaya, T. E. Svetoch, R. Z. Shaikhutdinova & S. V. Dentovskaya. (2020) A search for new molecular targets for optimizing plague preventive vaccination and therapy. Russian Journal of Infection and Immunity 11:2, pages 265-282.
Crossref
Crossref
Elahe Seyed Hosseini, Mehdi Zeinoddini, Ali Reza Saeedinia & Valiollah Babaeipour. (2020) Optimization and One-Step Purification of Recombinant V Antigen Production from Yersinia pestis. Molecular Biotechnology 62:3, pages 177-184.
Crossref
Crossref
Xiuran Wang, Amit K. Singh & Wei Sun. (2020) Protection and Safety Evaluation of Live Constructions Derived from the Pgm− and pPCP1− Yersinia pestis Strain. Vaccines 8:1, pages 95.
Crossref
Crossref
William Bowen, Lalit Batra, Amanda R. Pulsifer, Esma S. Yolcu, Matthew B. Lawrenz & Haval Shirwan. (2019) Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Vaccine 37:38, pages 5708-5716.
Crossref
Crossref
Jae-Llane Ditchburn & Ryan Hodgkins. (2019) Yersinia pestis, a problem of the past and a re-emerging threat. Biosafety and Health 1:2, pages 65-70.
Crossref
Crossref
Zaurbek Sagiyev, Almas Berdibekov, Tatyana Bolger, Almagul Merekenova, Svetlana Ashirova, Zamir Nurgozhin & Zhandos Dalibayev. (2019) Human response to live plague vaccine EV, Almaty region, Kazakhstan, 2014-2015. PLOS ONE 14:6, pages e0218366.
Crossref
Crossref
Wei Sun & Amit K. Singh. (2019) Plague vaccine: recent progress and prospects. npj Vaccines 4:1.
Crossref
Crossref
Vyacheslav M. Abramov, Igor V. Kosarev, Vladimir L. Motin, Valentin S. Khlebnikov, Raisa N. Vasilenko, Vadim K. Sakulin, Andrey V. Machulin, Vladimir N. Uversky & Andrey V. Karlyshev. (2019) Binding of LcrV protein from Yersinia pestis to human T-cells induces apoptosis, which is completely blocked by specific antibodies. International Journal of Biological Macromolecules 122, pages 1062-1070.
Crossref
Crossref
Ayelet Zauberman, Yaron Vagima, Avital Tidhar, Moshe Aftalion, David Gur, Shahar Rotem, Theodor Chitlaru, Yinon Levy & Emanuelle Mamroud. (2017) Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Stephen K. Tyring, Mark Burnett & Frank Mwesigye. 2017. Tropical Dermatology. Tropical Dermatology
359
375
.
Shailendra Kumar Verma & Urmil Tuteja. (2016) Plague Vaccine Development: Current Research and Future Trends. Frontiers in Immunology 7.
Crossref
Crossref
Jian Sha, Michelle L. Kirtley, Curtis Klages, Tatiana E. Erova, Maxim Telepnev, Duraisamy Ponnusamy, Eric C. Fitts, Wallace B. Baze, Satheesh K. Sivasubramani, William S. Lawrence, Igor Patrikeev, Jennifer E. Peel, Jourdan A. Andersson, Elena V. Kozlova, Bethany L. Tiner, Johnny W. Peterson, David McWilliams, Snehal Patel, Eric Rothe, Vladimir L. Motin & Ashok K. Chopra. (2016) A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Clinical and Vaccine Immunology 23:7, pages 586-600.
Crossref
Crossref
Wei Sun. 2016. Yersinia pestis: Retrospective and Perspective. Yersinia pestis: Retrospective and Perspective
313
360
.
Stephen J. Streatfield, Natasha Kushnir & Vidadi Yusibov. (2015) Plant‐produced candidate countermeasures against emerging and reemerging infections and bioterror agents. Plant Biotechnology Journal 13:8, pages 1136-1159.
Crossref
Crossref
Reeta Rai, Baijnath Das, Nageshwar Choudhary, Ayantika Talukdar & Donthamsetty Nageswara Rao. (2015) MAP of F1 and V antigens from Yersinia pestis astride innate and adaptive immune response. Microbial Pathogenesis 87, pages 13-20.
Crossref
Crossref
Patricia Fellows, Jessica Price, Shannon Martin, Karen Metcalfe, Robert Krile, Roy Barnewall, Mary Kate Hart & Hank Lockman. (2015) Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy. Clinical and Vaccine Immunology 22:9, pages 1070-1078.
Crossref
Crossref
Wei Sun, Shilpa Sanapala, Jeremy C. Henderson, Shandiin Sam, Joseph Olinzock, M. Stephen Trent & Roy CurtissIIIIII. (2014) LcrV Delivered via Type III Secretion System of Live Attenuated Yersinia pseudotuberculosis Enhances Immunogenicity against Pneumonic Plague. Infection and Immunity 82:10, pages 4390-4404.
Crossref
Crossref
Yujun Cui, Xianwei Yang, Xiao Xiao, Andrey P. Anisimov, Dongfang Li, Yanfeng Yan, Dongsheng Zhou, Minoarisoa Rajerison, Elisabeth Carniel, Mark Achtman, Ruifu Yang & Yajun Song. (2014) Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infection, Genetics and Evolution 26, pages 172-179.
Crossref
Crossref
Maya I. Ivanov, Jim Hill & James B. Bliska. (2014) Direct Neutralization of Type III Effector Translocation by the Variable Region of a Monoclonal Antibody to Yersinia pestis LcrV. Clinical and Vaccine Immunology 21:5, pages 667-673.
Crossref
Crossref
Dongyou LiuDongsheng Zhou & Ruifu Yang. 2014. Manual of Security Sensitive Microbes and Toxins. Manual of Security Sensitive Microbes and Toxins
403
412
.
T. Butler. (2014) Plague history: Yersin?s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines. Clinical Microbiology and Infection 20:3, pages 202-209.
Crossref
Crossref
Jessica Z. Kubicek-Sutherland, Douglas M. Heithoff, Selvi C. Ersoy, William R. Shimp & Michael J. Mahan. (2014) Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes. Vaccine 32:13, pages 1451-1459.
Crossref
Crossref
V.A. Feodorova, M.A. Khizhnyakova, A.M. Lyapina, M.V. Telepnev, O.V. Ulianova, E.P. Lyapina & V.L. Motin. (2014) Selectivity in IgG Subclass Response to Live Plague Vaccine in Humans. Procedia in Vaccinology 8, pages 34-37.
Crossref
Crossref
Wei Li, Shixia Wang & Shan Lu. (2013) Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine. Vaccines 2:1, pages 36-48.
Crossref
Crossref
Riyasat Ali, Sudhir Kumar, Raza Ali Naqvi & D.N. Rao. (2013) B and T cell epitope mapping and study the humoral and cell mediated immune response to B–T constructs of YscF antigen of Yersinia pestis. Comparative Immunology, Microbiology and Infectious Diseases 36:4, pages 365-378.
Crossref
Crossref
Anthony J. Hickey, Jr-Shiuan Lin, Lawrence W. Kummer, Frank M. Szaba, Debra K. Duso, Michael Tighe, Michelle A. Parent & Stephen T. Smiley. (2013) Intranasal Prophylaxis with CpG Oligodeoxynucleotide Can Protect against Yersinia pestis Infection. Infection and Immunity 81:6, pages 2123-2132.
Crossref
Crossref
Tatiana E. Erova, Jason A. Rosenzweig, Jian Sha, Giovanni Suarez, Johanna C. Sierra, Michelle L. Kirtley, Christina J. van Lier, Maxim V. Telepnev, Vladimir L. Motin & Ashok K. Chopra. (2013) Evaluation of Protective Potential of Yersinia pestis Outer Membrane Protein Antigens as Possible Candidates for a New-Generation Recombinant Plague Vaccine. Clinical and Vaccine Immunology 20:2, pages 227-238.
Crossref
Crossref
Bei Li, Chunhong Du, Lei Zhou, Yujing Bi, Xiaoyi Wang, Li Wen, Zhaobiao Guo, Zhizhong Song & Ruifu Yang. (2012) Humoral and Cellular Immune Responses to Yersinia pestis Infection in Long-Term Recovered Plague Patients. Clinical and Vaccine Immunology 19:2, pages 228-234.
Crossref
Crossref
V.A. Feodorov, A.M. Lyapina, O.V. Ulianova, T.I. Polyanina, Yu.Yu. Eliseev & V.L. Motin. (2012) High Potency of Novel Polymeric Adjuvant in Eliciting of the Immune Response in Mice to Major Antigens of Chlamydia and Yersinia. Procedia in Vaccinology 6, pages 93-97.
Crossref
Crossref
Devender Kumar, Girish Kirimanjeswara & Dennis W. Metzger. (2011) Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against Pneumonic Plague. Clinical and Vaccine Immunology 18:11, pages 1925-1935.
Crossref
Crossref
Mohan Natesan, Sarah Keasey & Robert G. Ulrich. 2011. BSL3 and BSL4 Agents. BSL3 and BSL4 Agents
167
178
.
Yinon Levy, Yehuda Flashner, Avital Tidhar, Ayelet Zauberman, Moshe Aftalion, Shirley Lazar, David Gur, Avigdor Shafferman & Emanuelle Mamroud. (2011) T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague. Vaccine 29:40, pages 6866-6873.
Crossref
Crossref
Jason A. Rosenzweig, Olufisayo Jejelowo, Jian Sha, Tatiana E. Erova, Sheri M. Brackman, Michelle L. Kirtley, Cristina J. van Lier & Ashok K. Chopra. (2011) Progress on plague vaccine development. Applied Microbiology and Biotechnology 91:2, pages 265-286.
Crossref
Crossref
Petra Oyston & Diane Williamson. (2011) Plague: Infections of Companion Animals and Opportunities for Intervention. Animals 1:2, pages 242-255.
Crossref
Crossref
Wei Sun, David Six, Xiaoying Kuang, Kenneth L. Roland, Christian R.H. Raetz & Roy CurtissIIIIII. (2011) A live attenuated strain of Yersinia pestis KIM as a vaccine against plague. Vaccine 29:16, pages 2986-2998.
Crossref
Crossref
Jr-Shiuan Lin, Lawrence W. Kummer, Frank M. Szaba & Stephen T. Smiley. (2011)
IL-17 Contributes to Cell-Mediated Defense against Pulmonary
Yersinia pestis
Infection
. The Journal of Immunology 186:3, pages 1675-1684.
Crossref
Crossref
Juliette K. Tinker, Chadwick T. Davis & Britni M. Arlian. (2010) Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV–cholera toxin A2/B chimeras. Protein Expression and Purification 74:1, pages 16-23.
Crossref
Crossref
Wang WANG, Zhi-Zhen QI, Qing-Wen ZHANG, Ben-Chuan WU, Zi-Wen ZHU, Yong-Hai YANG, Bai-Zhong CUI, Rui-Xia DAI, Ye-Feng QIU, Zu-Yun WANG, Zhao-Biao GUO, Tao-Xing SHI, Hu WANG, Rui-Fu YANG & Xiao-Yi WANG. (2010) Different Strategies for Preparation of Non-tagged rV270 Protein and Its Efficacy against Yersinia Pestis Challenge. Biomedical and Environmental Sciences 23:5, pages 333-340.
Crossref
Crossref
Joseph N. Brewoo, Tim D. Powell, Dan T. Stinchcomb & Jorge E. Osorio. (2010) Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice. Vaccine 28:36, pages 5891-5899.
Crossref
Crossref
Abby Jones, Catharine Bosio, Angela Duffy, Andrew Goodyear, Martin Schriefer & Steven Dow. (2010) Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Vaccine 28:36, pages 5924-5929.
Crossref
Crossref
Yehuda Flashner, Morly Fisher, Avital Tidhar, Adva Mechaly, David Gur, Gideon Halperin, Eran Zahavy, Emanuelle Mamroud & Sara Cohen. (2010)
The search for early markers of plague: evidence for accumulation of soluble
Yersinia pestis
LcrV in bubonic and pneumonic mouse models of disease
. FEMS Immunology & Medical Microbiology 59:2, pages 197-206.
Crossref
Crossref
Julie L. BoyerCarolina Sofer-PodestaJohn AngNeil R. HackettMaria J. ChiuchioloSvetlana SeninaDavid PerlinRonald G. Crystal. (2010)
Protective Immunity Against a Lethal Respiratory
Yersinia pestis
Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into Adenovirus Capsid
. Human Gene Therapy 21:7, pages 891-901.
Crossref
Crossref
Wei Sun, Kenneth L. Roland, Xiaoying Kuang, Christine G. Branger & Roy CurtissIIIIII. (2010)
Yersinia pestis
with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague
. Infection and Immunity 78:3, pages 1304-1313.
Crossref
Crossref
Nihal A. Okan, Patricio Mena, Jorge L. Benach, James B. Bliska & A. Wali Karzai. (2010)
The
smpB-ssrA
Mutant of
Yersinia pestis
Functions as a Live Attenuated Vaccine To Protect Mice against Pulmonary Plague Infection
. Infection and Immunity 78:3, pages 1284-1293.
Crossref
Crossref
V. V. Firstova, I. V. Bakhteeva, G. M. Titareva, E. V. Zyrina, S. A. Ivanov, N. V. Kisseleva, P. Kh. Kopylov, A. P. Anisimov & I. A. Dyatlov. (2010) Determination of the Expression of CD69 Marker of Early Activation in the Immune Mice Lymphocytes after their Stimulation with Plague Agent Antigens. Problems of Particularly Dangerous Infections:1(103), pages 56-59.
Crossref
Crossref
Zhizhen Qi, Lei Zhou, Qingwen Zhang, Lingling Ren, Ruixia Dai, Benchuan Wu, Tang Wang, Ziwen Zhu, Yonghai Yang, Baizhong Cui, Zuyun Wang, Hu Wang, Yefeng Qiu, Zhaobiao Guo, Ruifu Yang & Xiaoyi Wang. (2010) Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Vaccine 28:6, pages 1655-1660.
Crossref
Crossref
Ida M. Lister, Joan Mecsas & Stuart B. Levy. (2010)
Effect of MarA-Like Proteins on Antibiotic Resistance and Virulence in
Yersinia pestis
. Infection and Immunity 78:1, pages 364-371.
Crossref
Crossref
Tie Liu, Stacy L. Agar, Jian Sha & Ashok K. Chopra. (2010) Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: Role of Lpp in modulating host immune response, NF-?B activation and cell death. Microbial Pathogenesis 48:1, pages 42-52.
Crossref
Crossref
M. Lucrecia Alvarez & Guy A. Cardineau. (2010) Prevention of bubonic and pneumonic plague using plant-derived vaccines. Biotechnology Advances 28:1, pages 184-196.
Crossref
Crossref
LUCIANA BORIO & NOREEN A. HYNES. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
3965
3970
.
James B. Bliska. 2010. The Challenge of Highly Pathogenic Microorganisms. The Challenge of Highly Pathogenic Microorganisms
31
44
.
Shan Lu & Shixia Wang. (2009) Technical transformation of biodefense vaccines. Vaccine 27, pages D8-D15.
Crossref
Crossref
Frank M. Szaba, Lawrence W. Kummer, Lindsey B. Wilhelm, Jr-Shiuan Lin, Michelle A. Parent, Sara W. Montminy-Paquette, Egil Lien, Lawrence L. Johnson & Stephen T. Smiley. (2009)
D27-pLpxL, an Avirulent Strain of
Yersinia pestis
, Primes T Cells That Protect against Pneumonic Plague
. Infection and Immunity 77:10, pages 4295-4304.
Crossref
Crossref
Betty L. Noel, Sarit Lilo, Daniel Capurso, Jim Hill & James B. Bliska. (2009)
Yersinia pestis
Can Bypass Protective Antibodies to LcrV and Activation with Gamma Interferon To Survive and Induce Apoptosis in Murine Macrophages
. Clinical and Vaccine Immunology 16:10, pages 1457-1466.
Crossref
Crossref
Carolina Sofer-Podesta, John Ang, Neil R. Hackett, Svetlana Senina, David Perlin, Ronald G. Crystal & Julie L. Boyer. (2009)
Adenovirus-Mediated Delivery of an Anti-V Antigen Monoclonal Antibody Protects Mice against a Lethal
Yersinia pestis
Challenge
. Infection and Immunity 77:4, pages 1561-1568.
Crossref
Crossref
V.A. Feodorova, L.N. Pan?kina, E.P. Savostina, O.S. Kuznetsov, N.P. Konnov, L.V. Sayapina, S.V. Dentovskaya, R.Z. Shaikhutdinova, S.A. Ageev, B. Lindner, A.N. Kondakova, O.V. Bystrova, N.A. Kocharova, S.N. Senchenkova, O. Holst, G.B. Pier, Y.A. Knirel, A.P. Anisimov & V.L. Motin. (2009) Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens. Vaccine 27:16, pages 2240-2250.
Crossref
Crossref
Kei Amemiya, Jennifer L. Meyers, Taralyn E. Rogers, Randy L. Fast, Anthony D. Bassett, Patricia L. Worsham, Bradford S. Powell, Sarah L. Norris, Arthur M. Krieg & Jeffrey J. Adamovicz. (2009) CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Vaccine 27:16, pages 2220-2229.
Crossref
Crossref
Karina Ramirez, Alejandra V. E. Capozzo, Scott A. Lloyd, Marcelo B. Sztein, James P. Nataro & Marcela F. Pasetti. (2009)
Mucosally Delivered
Salmonella
Typhi Expressing the
Yersinia pestis
F1 Antigen Elicits Mucosal and Systemic Immunity Early in Life and Primes the Neonatal Immune System for a Vigorous Anamnestic Response to Parenteral F1 Boost
. The Journal of Immunology 182:2, pages 1211-1222.
Crossref
Crossref
Maya I. Ivanov, Betty L. Noel, Ryan Rampersaud, Patricio Mena, Jorge L. Benach & James B. Bliska. (2008)
Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1
−
Yersinia pestis
. Infection and Immunity 76:11, pages 5181-5190.
Crossref
Crossref
Anasuya Chattopadhyay, Steven Park, Guillaume Delmas, Rema Suresh, Svetlana Senina, David S. Perlin & John K. Rose. (2008) Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection. Vaccine 26:50, pages 6329-6337.
Crossref
Crossref
Richard T. Robinson, Shabaana A. Khader, Richard M. Locksley, Egil Lien, Stephen T. Smiley & Andrea M. Cooper. (2008)
Yersinia pestis
Evades TLR4-dependent Induction of IL-12(p40)2 by Dendritic Cells and Subsequent Cell Migration
. The Journal of Immunology 181:8, pages 5560-5567.
Crossref
Crossref
Stephen T. Smiley. (2008) Immune defense against pneumonic plague. Immunological Reviews 225:1, pages 256-271.
Crossref
Crossref
Tang Wang, Zhizhen Qi, Benchuan Wu, Ziwen Zhu, Yonghai Yang, Baizhong Cui, Ruixia Dai, Qingwen Zhang, Yefeng Qiu, Zuyun Wang, Hu Wang, Zhaobiao Guo, Xiaoyi Wang & Ruifu Yang. (2008) A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Protein Expression and Purification 61:1, pages 7-12.
Crossref
Crossref
Lauriane E. Quenee, Claire A. Cornelius, Nancy A. Ciletti, Derek Elli & Olaf Schneewind. (2008) Yersinia pestis caf1 Variants and the Limits of Plague Vaccine Protection. Infection and Immunity 76:5, pages 2025-2036.
Crossref
Crossref
Jian Sha, Stacy L. Agar, Wallace B. Baze, Juan P. Olano, Amin A. Fadl, Tatiana E. Erova, Shaofei Wang, Sheri M. Foltz, Giovanni Suarez, Vladimir L. Motin, Sadhana Chauhan, Gary R. Klimpel, Johnny W. Peterson & Ashok K. Chopra. (2008) Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague. Infection and Immunity 76:4, pages 1390-1409.
Crossref
Crossref
Ayelet Zauberman, Sara Cohen, Yinon Levy, Gideon Halperin, Shirley Lazar, Baruch Velan, Avigdor Shafferman, Yehuda Flashner & Emanuelle Mamroud. (2008) Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Vaccine 26:13, pages 1616-1625.
Crossref
Crossref
Jianmin li, Bing Li, Guanlin Li, Jun Ren, Jinlong Zhang, Chun?e Xu, Xiuxu Yang, Shuling Liu, Ling Fu & Wei Chen. (2008) Design and preparation of non-tagged Yersinia pestis LcrV antigen in Escherichia coli and its immunogenicity in BALB/c mice. Protein Expression and Purification 57:2, pages 136-142.
Crossref
Crossref
Bei Li, Dongsheng Zhou, Zuyun Wang, Zhizhong Song, Hu Wang, Min Li, Xingqi Dong, Mingshou Wu, Zhaobiao Guo & Ruifu Yang. (2008) Antibody profiling in plague patients by protein microarray. Microbes and Infection 10:1, pages 45-51.
Crossref
Crossref
Theresa J. Ochoa & Thomas G. Cleary. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
820
824
.
Vivian L. Braciale, Michael Nash, Namita Sinha, Irina V. Zudina & Vladimir L. Motin. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH
473
480
.
V.A. Feodorova, L.N. Pan?kina, E.P. Savostina, L.V. Sayapina, V.L. Motin, S.V. Dentovskaya, R.Z. Shaikhutdinova, S.A. Ivanov, B. Lindner, A.N. Kondakova, O.V. Bystrova, N.A. Kocharova, S.N. Senchenkova, O. Holst, G.B. Pier, Y.A. Knirel & A.P. Anisimov. (2007) A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. Vaccine 25:44, pages 7620-7628.
Crossref
Crossref
Michiel Van Eijck & Wolff‐Michael Roth. (2007) Keeping the local local: Recalibrating the status of science and traditional ecological knowledge (TEK) in education. Science Education 91:6, pages 926-947.
Crossref
Crossref
Jim E. Eyles, Wendy A. Butcher, Richard W. Titball & Jim Hill. (2007) Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Vaccine 25:42, pages 7301-7306.
Crossref
Crossref
Anna M. Kolodziejek, Dylan J. Sinclair, Keun S. Seo, Darren R. Schnider, Claudia F. Deobald, Harold N. Rohde, Austin K. Viall, Scott S. Minnich, Carolyn J. Hovde, Scott A. Minnich & Gregory A. Bohach. (2007) Phenotypic characterization of OmpX, an Ail homologue of Yersinia pestis KIM. Microbiology 153:9, pages 2941-2951.
Crossref
Crossref
Amanda B. DuBois, Lucy C. Freytag & John D. Clements. (2007) Evaluation of combinatorial vaccines against anthrax and plague in a murine model. Vaccine 25:24, pages 4747-4754.
Crossref
Crossref
Jeremy L. Goodin, David F. Nellis, Bradford S. Powell, Vinay V. Vyas, Jeffrey T. Enama, Lena C. Wang, Patrick K. Clark, Steven L. Giardina, Jeffery. J. Adamovicz & Dennis F. Michiel. (2007) Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein Expression and Purification 53:1, pages 63-79.
Crossref
Crossref
Stephen R. Morris. (2007) Development of a recombinant vaccine against aerosolized plague. Vaccine 25:16, pages 3115-3117.
Crossref
Crossref
Alexander V. Philipovskiy & Stephen T. Smiley. (2007) Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis Infection. Infection and Immunity 75:2, pages 878-885.
Crossref
Crossref
Amy Palin, Anasuya Chattopadhyay, Steven Park, Guillaume Delmas, Rema Suresh, Svetlana Senina, David S. Perlin & John K. Rose. (2007) An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine 25:4, pages 741-750.
Crossref
Crossref
Stefan D. Knight. 2007. The Genus Yersinia. The Genus Yersinia
74
87
.
Andrey P. Anisimov, Svetlana V. Dentovskaya, Tat'yana E. Svetoch & Evgeniy A. Panfertsev. 2007. The Genus Yersinia. The Genus Yersinia
23
27
.
David A. Chalton, Julie A. Musson, Helen Flick-Smith, Nicola Walker, Alistair McGregor, Heather K. Lamb, E. Diane Williamson, Julie Miller, John H. Robinson & Jeremy H. Lakey. (2006)
Immunogenicity of a
Yersinia pestis
Vaccine Antigen Monomerized by Circular Permutation
. Infection and Immunity 74:12, pages 6624-6631.
Crossref
Crossref
Baruch Velan, Erez Bar-Haim, Ayelet Zauberman, Emanuelle Mamroud, Avigdor Shafferman & Sara Cohen. (2006)
Discordance in the Effects of
Yersinia pestis
on the Dendritic Cell Functions Manifested by Induction of Maturation and Paralysis of Migration
. Infection and Immunity 74:11, pages 6365-6376.
Crossref
Crossref
Mikio Tanabe, Helen S. Atkins, David N. Harland, Stephen J. Elvin, Anthony J. Stagg, Osman Mirza, Richard W. Titball, Bernadette Byrne & Katherine A. Brown. (2006)
The ABC Transporter Protein OppA Provides Protection against Experimental
Yersinia pestis
Infection
. Infection and Immunity 74:6, pages 3687-3691.
Crossref
Crossref
Michelle A. Parent, Lindsey B. Wilhelm, Lawrence W. Kummer, Frank M. Szaba, Isis K. Mullarky & Stephen T. Smiley. (2006)
Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal Pulmonary
Yersinia pestis
Infection
. Infection and Immunity 74:6, pages 3381-3386.
Crossref
Crossref
Janak Koirala. (2006) Plague: Disease, Management, and Recognition of Act of Terrorism. Infectious Disease Clinics of North America 20:2, pages 273-287.
Crossref
Crossref
Jim Hill, Jim E. Eyles, Stephen J. Elvin, Gareth D. Healey, Roman A. Lukaszewski & Richard W. Titball. (2006) Administration of Antibody to the Lung Protects Mice against Pneumonic Plague. Infection and Immunity 74:5, pages 3068-3070.
Crossref
Crossref
Omar Lupi, Vandana Madkan & Stephen K. Tyring. (2006) Tropical dermatology: Bacterial tropical diseases. Journal of the American Academy of Dermatology 54:4, pages 559-578.
Crossref
Crossref
Moa Lavander, Solveig K. Ericsson, Jeanette E. Bröms & Åke Forsberg. (2006)
The Twin Arginine Translocation System Is Essential for Virulence of
Yersinia pseudotuberculosis
. Infection and Immunity 74:3, pages 1768-1776.
Crossref
Crossref
. 2006. Tropical Dermatology. Tropical Dermatology
359
374
.
Jyl S Matson, Kelly A Durick, David S Bradley & Matthew L Nilles. (2005) Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiology 5:1.
Crossref
Crossref
Michelle A. Parent, Kiera N. Berggren, Lawrence W. Kummer, Lindsey B. Wilhelm, Frank M. Szaba, Isis K. Mullarky & Stephen T. Smiley. (2005)
Cell-Mediated Protection against Pulmonary
Yersinia pestis
Infection
. Infection and Immunity 73:11, pages 7304-7310.
Crossref
Crossref
Clarissa Cowan, Alexander V. Philipovskiy, Christine R. Wulff-Strobel, Zhan Ye & Susan C. Straley. (2005)
Anti-LcrV Antibody Inhibits Delivery of Yops by
Yersinia pestis
KIM5 by Directly Promoting Phagocytosis
. Infection and Immunity 73:9, pages 6127-6137.
Crossref
Crossref
Katie A. Overheim, R. William DePaolo, Kristin L. DeBord, Elizabeth M. Morrin, Debra M. Anderson, Nathaniel M. Green, Robert R. Brubaker, Bana Jabri & Olaf Schneewind. (2005) LcrV Plague Vaccine with Altered Immunomodulatory Properties. Infection and Immunity 73:8, pages 5152-5159.
Crossref
Crossref
Victoria L. Taylor, Richard W. Titball & Petra C. F. Oyston. (2005) Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151:6, pages 1919-1926.
Crossref
Crossref
Anthony S. Fauci, Nancy A. Touchette & Gregory K. Folkers. (2005) Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases. Emerging Infectious Diseases 11:4, pages 519-525.
Crossref
Crossref
Michelle A. Parent, Kiera N. Berggren, Isis K. Mullarky, Frank M. Szaba, Lawrence W. Kummer, Jeffrey J. Adamovicz & Stephen T. Smiley. (2005)
Yersinia pestis
V Protein Epitopes Recognized by CD4 T Cells
. Infection and Immunity 73:4, pages 2197-2204.
Crossref
Crossref